Open AccessThe First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella
Author(s) -
Robert M. F. van der Put,
Carolien Smitsman,
Alex de Haan,
Martin Hamzink,
Hans Timmermans,
Joost P. Uittenbogaard,
Janny Westdijk,
Michiel Stork,
Olga Ophorst,
Françoise Thouron,
Catherine Guerreiro,
Philippe Sansonetti,
Armelle Phalipon,
Laurence A. Mulard
Publication year - 2022
Publication title -
acs central science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.893
H-Index - 76
eISSN - 2374-7951
pISSN - 2374-7943
DOI - 10.1021/acscentsci.1c01479
Subject(s) - immunogenicity , toxoid , conjugate vaccine , glycan , shigella flexneri , glycoconjugate , shigella , clostridium tetani , hapten , antigen , tetanus , microbiology and biotechnology , immunology , medicine , chemistry , biology , escherichia coli , vaccination , biochemistry , gene , glycoprotein
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom